SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs informs about closure of trading window

31 Dec 2021 Evaluate

Pursuant to the NSE circular no, NSE/CML/2019/11 and BSE circular no. LIST/COMP/01/2019-20 read with clause 4 of Schedule B of the SEBI (Prohibition of SEBI Insider Trading) Regulation, 2015, Lyka Labs has informed that the trading window for dealing in the equity shares of the Company by designated persons and their immediate relatives shall remain closed with effect from 01st January, 2022 to 48 hours after the declaration of un-audited Financial Results for the Third Quarter ended 31st December, 2021.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

59.00 0.28 (0.48%)
06-May-2026 10:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1839.60
Dr. Reddys Lab 1287.65
Cipla 1350.35
Zydus Lifesciences 935.80
Lupin 2415.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×